SynthesisFrontiers in immunology2022

Efficacy and safety of copanlisib in relapsed/refractory B-cell non-Hodgkin lymphoma: A meta-analysis of prospective clinical trials.

Jinjin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.